Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
Fisher Clinical Services, Inc. has submitted an application to the Drug Enforcement Administration (DEA) to be registered as an importer of one or more basic classes of controlled substances. This registration, if approved, would authorize the company to legally import specified controlled substances into the United States for clinical and pharmaceutical purposes. The notice serves as a public announcement of the application, allowing interested parties to review and potentially comment on the proposed registration. Fisher Clinical Services, as a clinical services provider, likely seeks this registration to support clinical trials and pharmaceutical research that require imported controlled substance materials. Under the Controlled Substances Act, any entity seeking to import controlled substances must obtain DEA registration. This process ensures federal oversight of the controlled substances supply chain and helps prevent diversion of these materials for illicit use. The public notice period is a standard regulatory step before the DEA makes a final determination on the application.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Fisher Clinical Services, Inc. has applied for DEA registration as a controlled substances importer effective April 2026
- Application covers one or more basic classes of controlled substances for importation into the United States
- Public notice period initiated allowing stakeholders to submit comments or objections to the proposed registration
+ 2 more changes with Pro
Obligations
What this law requires
Obtain DEA registration as an importer of controlled substances before importing any controlled substance materials into the United States
Submit a complete application to the Drug Enforcement Administration (DEA) specifying the basic class(es) of controlled substances intended to be imported
Comply with federal oversight requirements of the controlled substances supply chain as mandated by the Controlled Substances Act
Allow interested parties to review the application and submit comments during the public notice period before final DEA determination
Limit importation of controlled substances to authorized purposes (clinical trials and pharmaceutical research) as specified in the application